335 related articles for article (PubMed ID: 16084010)
1. Pattern of relapse after first line treatment of advanced stage germ-cell tumors.
Fléchon A; Culine S; Théodore C; Droz JP
Eur Urol; 2005 Dec; 48(6):957-63; discussion 963-4. PubMed ID: 16084010
[TBL] [Abstract][Full Text] [Related]
2. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
3. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
4. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
[TBL] [Abstract][Full Text] [Related]
5. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
6. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results.
Loehrer PJ; Mandelbaum I; Hui S; Clark S; Einhorn LH; Williams SD; Donohue JP
J Thorac Cardiovasc Surg; 1986 Oct; 92(4):676-83. PubMed ID: 3020319
[TBL] [Abstract][Full Text] [Related]
7. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
8. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
9. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
10. High dose chemotherapy as salvage treatment for unresectable late relapse germ cell tumors.
Lorch A; Rick O; Wündisch T; Hartmann JT; Bokemeyer C; Beyer J
J Urol; 2010 Jul; 184(1):168-73. PubMed ID: 20483152
[TBL] [Abstract][Full Text] [Related]
11. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
Haas RJ; Schmidt P; Göbel U; Harms D
Klin Padiatr; 1993; 205(4):225-30. PubMed ID: 8397320
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of malignant mediastinal nonseminomatous germ cell tumor.
Kang CH; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Feb; 85(2):379-84. PubMed ID: 18222229
[TBL] [Abstract][Full Text] [Related]
14. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
16. [Risk-guided after-care of testicular tumor].
Schölermann KH; Dettmann R; Hartmann M
Urologe A; 1996 Jul; 35(4):326-30. PubMed ID: 8928363
[TBL] [Abstract][Full Text] [Related]
17. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
18. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
19. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
[TBL] [Abstract][Full Text] [Related]
20. A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
Kesler KA; Rieger KM; Hammoud ZT; Kruter LE; Perkins SM; Turrentine MW; Schneider BP; Einhorn LH; Brown JW
Ann Thorac Surg; 2008 Feb; 85(2):371-8. PubMed ID: 18222228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
